Cargando…

Canagliflozin in Type 1 Diabetes: A Case Series of Patient Outcomes in a Diabetes Clinic

Detalles Bibliográficos
Autores principales:	Roberts, Tori Marie, Johnson, June Felice, Vaughan, Amy Grace
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2019
Materias:	Departments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380232/ https://www.ncbi.nlm.nih.gov/pubmed/30853764 http://dx.doi.org/10.2337/ds17-0018

Ejemplares similares

Euglycemic Diabetic Ketoacidosis Accompanied by Severe Hypophosphatemia During Recovery in a Patient With Type 2 Diabetes Being Treated With Canagliflozin/Metformin Combination Therapy
por: Shoukat, Sonia, et al.
Publicado: (2017)

Pediatric Case Series of Cystic Fibrosis, Diabetes, and Islet Cell Autoimmunity
por: Kim, Grace J., et al.
Publicado: (2018)

A Clinical Perspective of Canagliflozin in the Management of Type 2 Diabetes Mellitus
por: Nardolillo, AnneMarie, et al.
Publicado: (2014)

Clinical and Roentgenological Profiles of Five Patterns of Charcot Foot in Diabetes: A Case Series
por: Chakraborty, Partha P., et al.
Publicado: (2016)

Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes
por: Skelley, Jessica W, et al.
Publicado: (2018)

Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program
por: Erondu, Ngozi, et al.
Publicado: (2015)

Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes
por: Valentine, Virginia, et al.
Publicado: (2015)

Drug-Induced Falsely Low A1C: Report of a Case Series From a Diabetes Clinic
por: Mitchell, Kirsten, et al.
Publicado: (2018)

CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice
por: Woo, Vincent, et al.
Publicado: (2018)

Erratum: Drug-Induced Falsely Low A1C: Report of a Case Series From a Diabetes Clinic. Clinical Diabetes 2018;36:80–84 (DOI: 10.2337/cd17-0005)
por: Mitchell, Kirsten, et al.
Publicado: (2018)

Emerging treatments in type 2 diabetes: focus on canagliflozin
por: Rosiak, Marek, et al.
Publicado: (2014)

Canagliflozin Treatment in Patients with Type 2 Diabetes Mellitus
por: Triplitt, Curtis, et al.
Publicado: (2015)

A Novel Approach to Adolescents With Type 1 Diabetes: The Team Clinic Model
por: Raymond, Jennifer K., et al.
Publicado: (2015)

Canagliflozin: a novel treatment option for type 2 diabetes
por: Dietrich, Eric, et al.
Publicado: (2013)

Erratum: Stigma in People With Type 1 or Type 2 Diabetes. Clinical Diabetes 2017;35:27–34. DOI: 10.2337/cd16-0020
por: Liu, Nancy F., et al.
Publicado: (2017)

Team Clinic: Group Approach to Care of Early Adolescents With Type 1 Diabetes
por: McClain, Megan Rose, et al.
Publicado: (2018)

Patient profiling in diabetes and role of canagliflozin
por: Amblee, Ambika
Publicado: (2014)

Prolonged diabetic ketoacidosis associated with canagliflozin
por: Sloan, Gordon, et al.
Publicado: (2018)

Canagliflozin-associated diabetic ketoacidosis: a case report
por: Chai, Peter R., et al.
Publicado: (2017)

Fifty Years of Living With Type 1 Diabetes
por: Williams, Nora
Publicado: (2017)

Warts of the Fingertips in a Pediatric Patient With Type 1 Diabetes
por: Chan, Jacqueline T., et al.
Publicado: (2017)

HNF1β Diabetes or Maturity-Onset Diabetes of the Young Type 5 With Rare HNF1β Mutation: A Case Report
por: Haynes, Autumn L., et al.
Publicado: (2019)

First Presentation of Diabetes as Diabetic Ketoacidosis in a Case of Friedreich’s Ataxia
por: Chakraborty, Partha Pratim, et al.
Publicado: (2015)

Renal, cardiovascular and safety outcomes of canagliflozin in patients with type 2 diabetes and nephropathy in East and South‐East Asian countries: Results from the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial
por: Wada, Takashi, et al.
Publicado: (2021)

Retrospective Review of Maternal and Fetal Outcomes in Patients With Gestational Diabetes Mellitus in an Indigent Prenatal Clinic
por: Reece, Sara W., et al.
Publicado: (2018)

An Insurer-Based Diabetes Educator–Community Partnership: Leveraging Education and Diabetes Support (LEADS)
por: Siminerio, Linda M., et al.
Publicado: (2015)

A Sincere Thank You to the Reviewers of Clinical Diabetes
Publicado: (2018)

A Sincere Thank You to the Reviewers of Clinical Diabetes
Publicado: (2019)

Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2019)

Prolonged Severe Hypoglycemia in a Pediatric Patient With Type 1 Diabetes
por: Paz, Rachael A., et al.
Publicado: (2018)

Hemichorea-Hemiballism as the First Presentation of Type 2 Diabetes
por: Ray, Sayantan, et al.
Publicado: (2015)

Role of Noninsulin Therapies in the Treatment of Type 1 Diabetes
por: Lingow, Sara E., et al.
Publicado: (2019)

Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
por: Yagi, Shusuke, et al.
Publicado: (2017)

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program
por: Matthews, David R., et al.
Publicado: (2019)

Canagliflozin for Japanese patients with chronic heart failure and type II diabetes
por: Sezai, Akira, et al.
Publicado: (2019)

Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report
por: Fukuda, Masafumi, et al.
Publicado: (2020)

A Case of Euglycemic Diabetic Ketoacidosis Following Canagliflozin Therapy
por: Tuna, Kubra M, et al.
Publicado: (2021)

Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus
por: Kaushal, Shaveta, et al.
Publicado: (2014)

Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis
por: Buysman, Erin K., et al.
Publicado: (2015)

Pilot of Community-Based Diabetes Self-Management Support for Patients at an Urban Primary Care Clinic
por: Johnson, Pamela Jo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hemlut7kmfov2pr7k6t73fdpgi